Multinational pharmaceutical firm, Pfizer is expected to submit plans for a major expansion of its Grange Castle campus in South West Dublin, that is likely to see several hundred new jobs created at the site according to today's Irish Times.
The 90-acre site already houses one of the largest biotechnology plants in the world employing about 1,100 people and produces some of Pfizer’s biggest-selling drugs such as Enbrel for arthritis and the children’s vaccine Prevenar.
The US company, which earlier in this year was thwarted by the US government in its plans to move its headquarters here, plans to develop a new five-storey biopharma manufacturing unit in two phases.
This would add 34,500sq m to its Irish footprint - it will include new lab space, warehouse capacity, and 565 new car park spots.
The development is reported to be the firm's first major investment since the UK's referendum on EU membership.
"The planning approval is being sought to prepare for potential expansion which is contingent upon the continued successful clinical development of investigational compounds in Pfizer’s mid and late stage pipeline," the company said.
Pfizer has already invested $1.8bn in the Irish site.
